About Scott

Scott Rubin is a Vice President with PRECISIONadvisors. Scott has more than 18 years of experience in the healthcare industry and is an experienced biopharmaceutical industry market access leader, who draws upon his deep strategic management consulting, market access marketing and account based sales experience to provide insights and solutions across many aspects of product commercialization.

Scott’s areas of expertise include oncology, inflammation and immunology, neuroscience, market access, payer, value proposition development, pricing, distribution and dispensing channel strategy and provider selection, contracting strategy and execution, reimbursement, financial assistance, patient support programs, and field access support teams.

Prior to joining Precision, Scott was a Principal Consultant focusing on distribution and dispensing channel strategy for specialty, orphan/rare, and cell/gene therapies, channel provider selection, patient and provider support services strategy, and market access strategy. Scott also was a Director of Oncology Market Access Strategy at Eli Lilly and Company and led the market access launch strategy and execution for multiple oncology products.